- Home
- BCAB vs OCCI Comparison
BCAB vs OCCI Comparison
Compare BCAB & OCCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAB
- OCCI
- Stock Information
- Founded
- BCAB 2007
- OCCI N/A
- Country
- BCAB United States
- OCCI United States
- Employees
- BCAB N/A
- OCCI N/A
- Industry
- BCAB Medicinal Chemicals and Botanical Products
- OCCI Trusts Except Educational Religious and Charitable
- Sector
- BCAB Health Care
- OCCI Finance
- Exchange
- BCAB Nasdaq
- OCCI Nasdaq
- Market Cap
- BCAB 101.0M
- OCCI 117.5M
- IPO Year
- BCAB 2020
- OCCI N/A
- Fundamental
- Price
- BCAB $1.57
- OCCI $7.11
- Analyst Decision
- BCAB Buy
- OCCI
- Analyst Count
- BCAB 2
- OCCI 0
- Target Price
- BCAB $5.00
- OCCI N/A
- AVG Volume (30 Days)
- BCAB 1.2M
- OCCI 115.8K
- Earning Date
- BCAB 11-07-2024
- OCCI 12-11-2023
- Dividend Yield
- BCAB N/A
- OCCI 24.32%
- EPS Growth
- BCAB N/A
- OCCI N/A
- EPS
- BCAB N/A
- OCCI N/A
- Revenue
- BCAB $11,000,000.00
- OCCI N/A
- Revenue This Year
- BCAB N/A
- OCCI N/A
- Revenue Next Year
- BCAB N/A
- OCCI $10.19
- P/E Ratio
- BCAB N/A
- OCCI N/A
- Revenue Growth
- BCAB N/A
- OCCI N/A
- 52 Week Low
- BCAB $1.14
- OCCI $5.47
- 52 Week High
- BCAB $4.02
- OCCI $10.15
- Technical
- Relative Strength Index (RSI)
- BCAB 40.91
- OCCI 46.64
- Support Level
- BCAB $1.33
- OCCI $7.02
- Resistance Level
- BCAB $2.53
- OCCI $7.42
- Average True Range (ATR)
- BCAB 0.26
- OCCI 0.12
- MACD
- BCAB -0.07
- OCCI 0.01
- Stochastic Oscillator
- BCAB 20.08
- OCCI 29.55
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
About OCCI OFS Credit Company Inc.
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.